Know Cancer

or
forgot password

A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations


N/A
18 Years
N/A
Not Enrolling
Both
Mouth Cancer, Lip Cancer, Throat Cancer, Lip Neoplasms, Head and Neck Cancers

Thank you

Trial Information

A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations


Inclusion Criteria:



- Having a new diagnosis of Nasopharyngeal carcinoma.

- Being treated with either radiotherapy or chemoradiotherapy for this condition.

Exclusion Criteria:

- Age <18 since NPC is a very rare condition in this age group and may have a different
biological behavior

- Patients who are unable to provide informed consents for themselves.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Plasma Epstein-Bar Virus (EBV) DNA concentrations

Outcome Description:

measured by quantitative polymerase chain reaction (PCR)

Outcome Time Frame:

every 6 months until end of study

Safety Issue:

No

Principal Investigator

Quynh-Thu Le

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

ENT0006

NCT ID:

NCT00186433

Start Date:

November 2001

Completion Date:

June 2013

Related Keywords:

  • Mouth Cancer
  • Lip Cancer
  • Throat Cancer
  • Lip Neoplasms
  • Head and Neck Cancers
  • Neoplasms
  • Carcinoma
  • Head and Neck Neoplasms
  • Lip Neoplasms
  • Mouth Neoplasms
  • Nasopharyngeal Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317